- NGNE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
SC 13G Filing
Neurogene (NGNE) SC 13GAquinox Pharmaceuticals, Inc
Filed: 12 Feb 15, 12:00am
CUSIP No. 03842B101 | Schedule 13G | Page14 of14 |
EXHIBIT 99.1
JOINT FILING AGREEMENT
We, the undersigned, hereby express our agreement that the attached Schedule 13G is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. This agreement may be terminated with respect to the obligations to jointly file future amendments to such statement on Schedule 13G as to any of the undersigned upon such person giving written notice thereof to each of the other persons signatory hereto, at the principal office thereof.
Dated: February 12, 2015
AUGMENT INVESTMENTS LTD. | ||
By: | /s/ Pantelitsa Sofokleous | |
Name: Pantelitsa Sofokleous | ||
Title: Director | ||
By: | /s/ Maria Christina Stephanou | |
Name: Maria Christina Stephanou | ||
Title: Director |
/s/ Maria Christina Stephanou |
Maria Christina Stephanou |
/s/ Pantelitsa Sofokleous |
Pantelitsa Sofokleous |
/s/ Viktor Kharitonin |
Viktor Kharitonin |
/s/ Egor Kulkov |
Egor Kulkov |